Syncom Formulations (India) Ltd
28 March 2025 01:06|BSE : 524470|NSE : SYNCOMF|ISIN : INE312C01025
28 March 2025 01:06|BSE : 524470
NSE : SYNCOMF|ISIN : INE312C01025
Syncom Formulations India a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur (30kms away from Indore, the commercial capital of Madhya Pradesh, India). Established in the year 1988, Syncom’s state of art WHO-GMP and ISO 9001-2015 certi?ed plant is geared up with latest production machineries and maintains high quality standards. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.
Syncom Formulations India a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur (30kms away from Indore, the commercial capital of Madhya Pradesh, India). Established in the year 1988, Syncom’s state of art WHO-GMP and ISO 9001-2015 certi?ed plant is geared up with latest production machineries and maintains high quality standards. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.
FAQs
How to buy Syncom Formulations (India) Ltd shares?
What is the current Market Cap of Syncom Formulations (India) Ltd?
What is the current PE and PB ratio of Syncom Formulations (India) Ltd?
Open Free Demat Account
Kickstart your investment journey
